Search
for
Sort by
Research 31–60 of 1000+
- Comparative Outcomes of Cutaneous Vesicostomy Versus Cystoscopic Valve Ablation in the Initial Management of Posterior Urethral Valves
- The Effect of Finasteride on the Expression of Vascular Endothelial Growth Factor and Microvessel Density: A Possible Mechanism for Decreased Prostatic Bleeding in Treated Patients
- Medikamentöse Therapie des benignen Prostatasyndroms mit α1-Rezeptorblockern Grundlagen und klinische Ergebnisse
- titanflow
- Finasteride as a Neo-Adjuvant Treatment for TURPLiterature Review
- Efficacy and Safety of Thermobalancing Therapy in Men with Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia was Confirmed by Clinical Trial
- 1406 DETECTION OF MEMBRANE ANDROGEN-BINDING SITE IN LIVING RAT PROSTATE AND EVALUATION OF ITS ROLE IN PROSTATE BLOOD FLOW REGULATION
- The role of dutasteride in the treatment of benign prostatic obstruction and related conditions
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Dutasteride: A Review of its Use in the Management of Prostate Disorders
- Inhibitory Effects of Pueraria mirifica Aqueous Extracts on 5α-reductase and Prostate Histomorphometry in Testosterone-induced Benign Prostatic Hyperplasia Sprague Dawley Rats
- Finasteride para disminuir el sangrado en resección transuretral de próstata en pacientes con sonda Foley
- UP-02.010 Urinary PSA: Marker of Benign Prostatic Hyperplasia?
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- Effect of the ethanol extract of Syzygium aromaticum (clove) leaves on the lipid profile and body weight in testosterone-induced benign prostatic hyperplasia rats
- Are PSA adjustments necessary for prostate cancer screening in men taking finasteride for hair loss?
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
- Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats
- Efeitos do uso da finasterida sobre o volume prostático e dosagem sérica do PSA em pacientes jovens
- Efectos de la terapia combinada del D-004 y el Finasteride sobre la hiperplasia de próstata inducida por testosterona en ratas
- S89 Clinical outcomes of high risk prostate adenocarcinoma (T3 and Gleason score ≥8)
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Prostate-Specific Antigen as a Marker of Hyperandrogenism in Women and Its Implications for Antidoping
- Endocrine control of benign prostatic hyperplasia
- What do we know about phytotherapy of benign prostatic hyperplasia?
- Comparison of Intraoperative Blood Loss in Patients With Benign Prostatic Hyperplasia Undergoing Bipolar Transurethral Resection of the Prostate With and Without Preoperative Oral Finasteride
- Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review
- A herbal formula, comprising Panax ginseng and bee-pollen, inhibits development of testosterone-induced benign prostatic hyperplasia in male Wistar rats
- Purple corn extract improves benign prostatic hyperplasia by inhibiting 5 alpha-reductase type 2 and inflammation in testosterone propionate-induced rats